Pramlintide

Category DIABETTES

Pramlintide is a synthetic analog of amylin, a hormone that is produced by the pancreas and released into the bloodstream after a meal

Additional information

CAS	196078-30-5
Sequence	Lys-C[Cys-Asn-Thr-Ala-Thr-Cys]-Ala-Thr-Gln-Arg-Leu-Ala-Asn-Phe-Leu-Val-His-Ser-Ser-Asn-Asn-Phe-Phe-Pro-Ile-Leu-Pro-Pro-Thr-Asn-Val-Gly-Ser-Asn-Thr-Tyr-NH2
Molecular Formula	C171H269N51O53S2
Molar Mass	3951.41 g/mol
Purity	≥98%
Storage Conditions	2-8℃
Packing Specifications	100mg、1g、10g、100g or at customers request

Type 1 Diabetes: Pramlintide is used as an adjunct treatment in patients who use mealtime insulin therapy and who have failed to achieve desired glucose control despite optimal insulin therapy.
Type 2 Diabetes: It is used as an adjunct treatment in patients who use mealtime insulin therapy and who have failed to achieve desired glucose control despite optimal insulin therapy.
Weight Loss: Although it is not specifically approved for weight loss, some patients may experience weight loss as a side effect of treatment because pramlintide slows gastric emptying and promotes satiety.